Lila Biologics, Inc.
Biotechnology company · Seattle, Washington, United States
Lila Biologics, Inc. is a biotechnology company headquartered in Seattle, Washington, United States. Its earliest recorded incorporation is in 2022. It has received 1 NIH small-business research grant, $605,981 in total. It has reported private securities offerings to the US SEC, most recently $9.5 million sold in a notice filed in 2023.
Lila Biologics at a glance
What does Lila Biologics do?
US government research funding
1 NIH small-business research grant, $605,981 in total. NIH funding came from the National Heart, Lung, and Blood Institute.
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $9.5 million sold (2023).
Frequently asked questions about Lila Biologics
Where is Lila Biologics headquartered?
Lila Biologics, Inc. is headquartered in Seattle, Washington, United States.
What does Lila Biologics do?
Lila Biologics, Inc. is a biotechnology company.
When was Lila Biologics founded?
The earliest incorporation on record for Lila Biologics, Inc. is in 2022, according to public company registers.
Similar companies
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Kineta, Inc.Seattle, Washington, United States
- Avm Biotechnology, LLCSeattle, Washington, United States
- Lumen Bioscience, Inc.Seattle, Washington, United States
- Presage Biosciences, Inc.Seattle, Washington, United States
- Sana Biotechnology, Inc.Seattle, Washington, United States
- Phase Genomics, Inc.Seattle, Washington, United States
- Soovu Labs, Inc.Seattle, Washington, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences